SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-042176
Filing Date
2023-11-20
Accepted
2023-11-20 17:29:50
Documents
74
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1263772
2 ex31-1.htm EX-31.1 17780
3 ex31-2.htm EX-31.2 17817
4 ex32-1.htm EX-32.1 8300
5 ex32-2.htm EX-32.2 8297
  Complete submission text file 0001493152-23-042176.txt   6573837

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdt-20230930.xsd EX-101.SCH 62285
7 XBRL CALCULATION FILE cdt-20230930_cal.xml EX-101.CAL 70523
8 XBRL DEFINITION FILE cdt-20230930_def.xml EX-101.DEF 257462
9 XBRL LABEL FILE cdt-20230930_lab.xml EX-101.LAB 424841
10 XBRL PRESENTATION FILE cdt-20230930_pre.xml EX-101.PRE 348493
68 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 928562
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41245 | Film No.: 231423748
SIC: 2834 Pharmaceutical Preparations